查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
神經調節劑的全球市場：2024-2034
市場調查報告書
商品編碼
1418674

神經調節劑的全球市場：2024-2034

Neuromodulation Devices Market Report 2024-2034
出版日期: | 出版商: Visiongain Reports Ltd. | 英文 251 Pages | 商品交期: 最快1-2個工作天內

價格

到 2034 年，全球神經調節劑市場規模預計將以 12.4% 的複合年增長率成長。

由於應用範圍擴大、技術進步、良好的臨床結果、神經學研究的進步以及患者和醫療保健提供者意識的提高等因素，神經調節領域對深部腦部刺激（DBS）的需求正在顯著增加，呈現突然增加的趨勢。這種快速成長反映出人們越來越接受 DBS 作為多種神經系統疾病的有效治療介入措施。神經調節領域的持續發展促進了對 DBS 需求的增加，在解決多種疾病狀態和改善患者預後方面顯示出希望。

本報告調查了全球神經調節設備市場，並提供了市場概況、影響市場增長和市場機會的因素分析、市場規模趨勢和預測、各個細分市場和地區的詳細分析、競爭格局和關鍵信息。

目錄

第一章 報告概述

第 2 章執行摘要

第三章市場概況

  • 主要發現
  • 市場動態
    • 市場驅動力
    • 市場制約因素
    • 市場機會
  • COVID-19 影響分析
  • 波特五力分析
  • PEST分析

第四章神經調節劑市場分析：依產品

  • 主要發現
  • 市場吸引力指數
  • 市場規模趨勢和預測
  • 深部腦部刺激器
  • 胃電刺激器
  • 脊髓刺激器
  • 薦神經刺激器
  • 迷走神經刺激器
  • 經皮神經電刺激儀
  • 其他
    • 市場規模趨勢與預測：按地區
    • 市佔率：按地區

第五章神經調節劑市場分析：依應用分類

  • 主要發現
  • 市場吸引力指數
  • 市場規模趨勢和預測
  • 疼痛管理
  • 癲癇
  • 特發性震顫
  • 尿失禁和大便失禁
  • 沮喪
  • 肌張力失調
  • 胃輕癱
  • 帕金森病
  • 其他
    • 市場規模趨勢與預測：按地區
    • 市佔率：按地區

第六章神經調節劑市場分析：按地區

  • 主要發現
  • 市場規模趨勢和預測

第七章北美神經調節劑市場分析

第八章歐洲神經調節劑市場分析

第九章亞太神經調節劑市場分析

第十章拉丁美洲神經調節劑市場分析

第十一章中東與非洲神經調節因子市場分析

第十二章公司簡介

  • 競爭格局
  • 戰略視角
  • Abbott
  • Boston Scientific Corporation
  • electroCore, Inc.
  • Helbling Holding AG
  • Innovative Health Solutions
  • LivaNova PLC
  • Medtronic
  • MicroTransponder Inc.
  • Neuronetics Inc.
  • Parasym
  • Synapse Biomedical Inc
  • tVNS Technologies GmbH

第 13 章 一般評論/建議

  • Visiongain 的一般討論
  • 對參與企業的建議
Product Code: PHA1310

The global Neuromodulation Devices market is estimated to grow at a CAGR of 12.4% by 2034.

“The Neuromodulation devices market Report 2024-2034”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Surging Demand for Deep Brain Stimulation (DBS) in Neuromodulation

The demand for deep brain stimulation (DBS) in neuromodulation has experienced a notable surge, driven by factors such as expanded applications, technological advancements, positive clinical outcomes, progress in neurological research, and increased awareness among patients and healthcare providers. This surge reflects the growing acceptance of DBS as an effective therapeutic intervention for various neurological disorders. Ongoing developments in the field of neuromodulation continue to contribute to the increased demand for DBS, showcasing its potential to address diverse medical conditions and improve patient outcomes.

Complications Associated with Usage of Neuromodulation Devices

The use of neuromodulation devices, while offering therapeutic benefits, is not without potential complications. Complications associated with these devices can include infection at the implantation site, hardware malfunctions, lead migration or breakage, and adverse reactions to electrical stimulation. Additionally, patients may experience side effects such as tingling, pain, or muscle contractions. Proper patient selection, precise surgical placement, and ongoing monitoring are crucial to minimizing risks. Despite the efficacy of neuromodulation, the potential for complications underscores the importance of careful patient evaluation, thorough preoperative planning, and vigilant postoperative management to ensure the safe and effective use of these devices in managing various neurological conditions.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the Neuromodulation devices market evolving?
  • What is driving and restraining the neuromodulation devices market?
  • How will each neuromodulation devices submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
  • How will the market shares for each Neuromodulation devices submarket develop from 2024 to 2034?
  • What will be the main driver for the overall market from 2024 to 2034?
  • Will leading neuromodulation devices markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the neuromodulation devices projects for these leading companies?
  • How will the industry evolve during the period between 2024 and 2034? What are the implications of neuromodulation devices projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the neuromodulation devices market?
  • Where is the neuromodulation devices market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Neuromodulation devices market today, and over the next 10 years:

  • Our 251-page report provides 96 tables and 133 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Neuromodulation devices market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Neuromodulation devices prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

By Product

  • Deep Brain Stimulator
  • Gastric Electric Stimulator
  • Spinal Cord Stimulator
  • Sacral Nerve Stimulator
  • Vagus Nerve Stimulator
  • Transcutaneous Electrical Nerve Stimulator
  • Others

By Application

  • Pain Management
  • Epilepsy
  • Essential Tremor
  • Urinary and Fecal Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson's Disease
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 21 leading national markets

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Neuromodulation devices market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies profiled in the report:

  • Abbott
  • Boston Scientific Corporation
  • electroCore, Inc.
  • Helbling Holding AG
  • Innovative Health Solutions
  • LivaNova PLC
  • Medtronic
  • MicroTransponder Inc.
  • Neuronetics Inc.
  • Parasym
  • Synapse Biomedical Inc.
  • tVNS Technologies GmbH

Overall world revenue for Neuromodulation devices market, 2024 to 2034 in terms of value the market will surpass US$10.0 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the “Neuromodulation devices market, 2024 to 2034” report help you?

In summary, our 250+ page report provides you with the following knowledge:

  • Revenue forecasts to 2034 for Neuromodulation devices market, 2024 to 2034 Market, with forecasts for product, application and route of administration, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2034 for five regional and 21 key national markets - See forecasts for the Neuromodulation devices market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 12 of the major companies involved in the Neuromodulation devices market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Neuromodulation devices market 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Neuromodulation Devices Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Growing Demand for Deep Brain Stimulator Neuromodulation Devices in Pharmaceutical and Biotechnology Industry
      • 3.2.1.2 Rising Prevalence of Neurological Disorders and Nerve Injuries
      • 3.2.1.3 Growing Preference Among Patients for Non-invasive Treatments
      • 3.2.1.4 Expanded Therapeutic Applications of Neuromodulation Devices
      • 3.2.1.5 Technological Advancements in Neuromodulation Devices
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Complications Associated with Usage of Neuromodulation Devices
      • 3.2.2.2 High Cost of Neuromodulation Devices
      • 3.2.2.3 Stringent Regulatory Framework and a Thorough Approval Process
      • 3.2.2.4 Preference for Drug Therapies over Neuromodulation Products
      • 3.2.2.5 Product Recalls in the Neuromodulation Devices
      • 3.2.2.6 Lack of Skilled Healthcare Practitioners
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Rising Demand for Minimally Invasive Surgeries in Developed Countries
      • 3.2.3.2 Increasing Number of Elderly Patients with Neurological Disorders
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat from Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Neuromodulation Devices Market Analysis by Product

  • 4.1 Key Findings
  • 4.2 Product Segment: Market Attractiveness Index
  • 4.3 Neuromodulation Devices Market Size Estimation and Forecast by Product
  • 4.4 Deep Brain Stimulator
    • 4.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5 Gastric Electric Stimulator
    • 4.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.5.2 Market Share by Region, 2024 & 2034 (%)
  • 4.6 Spinal Cord Stimulator
    • 4.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.6.2 Market Share by Region, 2024 & 2034 (%)
  • 4.7 Sacral Nerve Stimulator
    • 4.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.7.2 Market Share by Region, 2024 & 2034 (%)
  • 4.8 Vagus Nerve Stimulator
    • 4.8.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.8.2 Market Share by Region, 2024 & 2034 (%)
  • 4.9 Transcutaneous Electrical Nerve Stimulator
    • 4.9.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.9.2 Market Share by Region, 2024 & 2034 (%)
  • 4.10 Others
    • 4.10.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.10.2 Market Share by Region, 2024 & 2034 (%)

5 Neuromodulation Devices Market Analysis by Application

  • 5.1 Key Findings
  • 5.2 Application Segment: Market Attractiveness Index
  • 5.3 Neuromodulation Devices Market Size Estimation and Forecast by Application
  • 5.4 Pain Management
    • 5.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.4.2 Market Share by Region, 2024 & 2034 (%)
  • 5.5 Epilepsy
    • 5.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.5.2 Market Share by Region, 2024 & 2034 (%)
  • 5.6 Essential Tremor
    • 5.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.6.2 Market Share by Region, 2024 & 2034 (%)
  • 5.7 Urinary and Fecal Incontinence
    • 5.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.7.2 Market Share by Region, 2024 & 2034 (%)
  • 5.8 Depression
    • 5.8.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.8.2 Market Share by Region, 2024 & 2034 (%)
  • 5.9 Dystonia
    • 5.9.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.9.2 Market Share by Region, 2024 & 2034 (%)
  • 5.10 Gastroparesis
    • 5.10.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.10.2 Market Share by Region, 2024 & 2034 (%)
  • 5.11 Parkinson's Disease
    • 5.11.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.11.2 Market Share by Region, 2024 & 2034 (%)
  • 5.12 Others
    • 5.12.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.12.2 Market Share by Region, 2024 & 2034 (%)

6 Neuromodulation Devices Market Analysis by Region

  • 6.1 Key Findings
  • 6.2 Regional Market Size Estimation and Forecast

7 North America Neuromodulation Devices Market Analysis

  • 7.1 Key Findings
  • 7.2 North America Neuromodulation Devices Market Attractiveness Index
  • 7.3 North America Neuromodulation Devices Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 7.4 North America Neuromodulation Devices Market Size Estimation and Forecast by Country
  • 7.5 North America Neuromodulation Devices Market Size Estimation and Forecast by Product
  • 7.6 North America Neuromodulation Devices Market Size Estimation and Forecast by Application
  • 7.7 U.S. Neuromodulation Devices Market Analysis
  • 7.8 Canada Neuromodulation Devices Market Analysis

8 Europe Neuromodulation Devices Market Analysis

  • 8.1 Key Findings
  • 8.2 Europe Neuromodulation Devices Market Attractiveness Index
  • 8.3 Europe Neuromodulation Devices Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 8.4 Europe Neuromodulation Devices Market Size Estimation and Forecast by Country
  • 8.5 Europe Neuromodulation Devices Market Size Estimation and Forecast by Product
  • 8.6 Europe Neuromodulation Devices Market Size Estimation and Forecast by Application
  • 8.7 Germany Neuromodulation Devices Market Analysis
  • 8.8 France Neuromodulation Devices Market Analysis
  • 8.9 UK Neuromodulation Devices Market Analysis
  • 8.10 Italy Neuromodulation Devices Market Analysis
  • 8.11 Spain Neuromodulation Devices Market Analysis
  • 8.12 Russia Neuromodulation Devices Market Analysis
  • 8.13 Rest of Europe Neuromodulation Devices Market Analysis

9 Asia Pacific Neuromodulation Devices Market Analysis

  • 9.1 Key Findings
  • 9.2 Asia Pacific Neuromodulation Devices Market Attractiveness Index
  • 9.3 Asia Pacific Neuromodulation Devices Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 9.4 Asia Pacific Neuromodulation Devices Market Size Estimation and Forecast by Country
  • 9.5 Asia Pacific Neuromodulation Devices Market Size Estimation and Forecast by Product
  • 9.6 Asia Pacific Neuromodulation Devices Market Size Estimation and Forecast by Application
  • 9.7 Japan Neuromodulation Devices Market Analysis
  • 9.8 China Neuromodulation Devices Market Analysis
  • 9.9 India Neuromodulation Devices Market Analysis
  • 9.10 Australia Neuromodulation Devices Market Analysis
  • 9.11 South Korea Neuromodulation Devices Market Analysis
  • 9.12 Rest of Asia Pacific Neuromodulation Devices Market Analysis

10 Latin America Neuromodulation Devices Market Analysis

  • 10.1 Key Findings
  • 10.2 Latin America Neuromodulation Devices Market Attractiveness Index
  • 10.3 Latin America Neuromodulation Devices Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 10.4 Latin America Neuromodulation Devices Market Size Estimation and Forecast by Country
  • 10.5 Latin America Neuromodulation Devices Market Size Estimation and Forecast by Product
  • 10.6 Latin America Neuromodulation Devices Market Size Estimation and Forecast by Application
  • 10.7 Brazil Neuromodulation Devices Market Analysis
  • 10.8 Mexico Neuromodulation Devices Market Analysis
  • 10.9 Rest of Latin America Neuromodulation Devices Market Analysis

11 MEA Neuromodulation Devices Market Analysis

  • 11.1 Key Findings
  • 11.2 MEA Neuromodulation Devices Market Attractiveness Index
  • 11.3 MEA Neuromodulation Devices Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 11.4 MEA Neuromodulation Devices Market Size Estimation and Forecast by Country
  • 11.5 MEA Neuromodulation Devices Market Size Estimation and Forecast by Product
  • 11.6 MEA Neuromodulation Devices Market Size Estimation and Forecast by Application
  • 11.7 GCC Neuromodulation Devices Market Analysis
  • 11.8 South Africa Neuromodulation Devices Market Analysis
  • 11.9 Rest of MEA Neuromodulation Devices Market Analysis

12 Company Profiles

  • 12.1 Competitive Landscape, 2022
  • 12.2 Strategic Outlook
  • 12.3 Abbott
    • 12.3.1 Company Snapshot
    • 12.3.2 Company Overview
    • 12.3.3 Financial Analysis
      • 12.3.3.1 Net Revenue, 2017-2022
      • 12.3.3.2 R&D, 2017-2022
      • 12.3.3.3 Regional Market Shares, 2022
    • 12.3.4 Product Benchmarking
    • 12.3.5 Strategic Outlook
  • 12.4 Boston Scientific Corporation
    • 12.4.1 Company Snapshot
    • 12.4.2 Company Overview
    • 12.4.3 Financial Analysis
      • 12.4.3.1 Net Revenue, 2017-2022
      • 12.4.3.2 R&D, 2017-2022
      • 12.4.3.3 Regional Market Shares, 2022
    • 12.4.4 Product Benchmarking
    • 12.4.5 Strategic Outlook
  • 12.5 electroCore, Inc.
    • 12.5.1 Company Snapshot
    • 12.5.2 Company Overview
    • 12.5.3 Financial Analysis
      • 12.5.3.1 Net Revenue, 2017-2022
      • 12.5.3.2 R&D, 2017-2022
      • 12.5.3.3 Regional Market Shares, 2022
    • 12.5.4 Product Benchmarking
    • 12.5.5 Strategic Outlook
  • 12.6 Helbling Holding AG
    • 12.6.1 Company Snapshot
    • 12.6.2 Company Overview
    • 12.6.3 Financial Analysis
      • 12.6.3.1 Net Revenue, 2017-2022
    • 12.6.4 Product Benchmarking
    • 12.6.5 Strategic Outlook
  • 12.7 Innovative Health Solutions
    • 12.7.1 Company Snapshot
    • 12.7.2 Company Overview
    • 12.7.3 Product Benchmarking
  • 12.8 LivaNova PLC
    • 12.8.1 Company Snapshot
    • 12.8.2 Company Overview
    • 12.8.3 Financial Analysis
      • 12.8.3.1 Net Revenue, 2017-2022
      • 12.8.3.2 R&D, 2017-2022
      • 12.8.3.3 Regional Market Shares, 2022
    • 12.8.4 Product Benchmarking
    • 12.8.5 Strategic Outlook
  • 12.9 Medtronic
    • 12.9.1 Company Snapshot
    • 12.9.2 Company Overview
    • 12.9.3 Financial Analysis
      • 12.9.3.1 Net Revenue, 2017-2022
      • 12.9.3.2 R&D, 2017-2022
      • 12.9.3.3 Regional Market Shares, 2022
    • 12.9.4 Product Benchmarking
    • 12.9.5 Strategic Outlook
  • 12.10 MicroTransponder Inc.
    • 12.10.1 Company Snapshot
    • 12.10.2 Company Overview
    • 12.10.3 Product Benchmarking
    • 12.10.4 Strategic Outlook
  • 12.11 Neuronetics Inc.
    • 12.11.1 Company Snapshot
    • 12.11.2 Company Overview
    • 12.11.3 Financial Analysis
      • 12.11.3.1 Net Revenue, 2017-2022
      • 12.11.3.2 R&D, 2017-2022
      • 12.11.3.3 Regional Market Shares, 2022
    • 12.11.4 Product Benchmarking
    • 12.11.5 Strategic Outlook
  • 12.12 Parasym
    • 12.12.1 Company Snapshot
    • 12.12.2 Company Overview
    • 12.12.3 Product Benchmarking
    • 12.12.4 Strategic Outlook
  • 12.13 Synapse Biomedical Inc
    • 12.13.1 Company Snapshot
    • 12.13.2 Company Overview
    • 12.13.3 Product Benchmarking
    • 12.13.4 Strategic Outlook
  • 12.14 tVNS Technologies GmbH
    • 12.14.1 Company Snapshot
    • 12.14.2 Company Overview
    • 12.14.3 Product Benchmarking
    • 12.14.4 Strategic Outlook

13 Conclusion and Recommendations

  • 13.1 Concluding Remarks from Visiongain
  • 13.2 Recommendations for Market Players

List of Tables

  • Table 1 Neuromodulation Devices Market Snapshot, 2024 & 2034 (US$ Million, CAGR %)
  • Table 2 Neuromodulation Devices Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 3 Neuromodulation Devices Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 4 Neuromodulation Devices Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 5 Neuromodulation Devices Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 6 Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 7 Deep Brain Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 8 Gastric Electric Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 9 Spinal Cord Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 10 Sacral Nerve Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 11 Vagus Nerve Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 12 Transcutaneous Electrical Nerve Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 13 Others Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 14 Neuromodulation Devices Market Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 15 Pain Management Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 16 Epilepsy Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 17 Essential Tremor Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 18 Urinary and Fecal Incontinence Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 19 Depression Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 20 Dystonia Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 21 Gastroparesis Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 22 Parkinson's Disease Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 23 Others Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 24 Neuromodulation Devices Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 25 North America Neuromodulation Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 26 North America Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 27 North America Neuromodulation Devices Market Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 28 U.S. Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 29 Canada Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 30 Europe Neuromodulation Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 31 Europe Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 32 Europe Neuromodulation Devices Market Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 33 Germany Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 34 France Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 35 UK Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 36 Italy Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 37 Spain Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 38 Russia Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 39 Rest of Europe Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 40 Asia Pacific Neuromodulation Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 41 Asia Pacific Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 42 Asia Pacific Neuromodulation Devices Market Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 43 Japan Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 44 China Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 45 India Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 46 Australia Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 47 South Korea Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 48 Rest of Asia Pacific Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 49 Latin America Neuromodulation Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 50 Latin America Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 51 Latin America Neuromodulation Devices Market Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 52 Brazil Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 53 Mexico Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 54 Rest of Latin America Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 55 MEA Neuromodulation Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 56 MEA Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 57 MEA Neuromodulation Devices Market Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 58 GCC Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 59 South Africa Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 60 Rest of MEA Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 61 Strategic Outlook
  • Table 62 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 63 Abbott: Product Benchmarking
  • Table 64 Abbott.: Strategic Outlook
  • Table 65 Boston Scientific Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 66 Boston Scientific Corporation, Inc.: Product Benchmarking
  • Table 67 Boston Scientific Corporation, Inc.: Strategic Outlook
  • Table 68 electroCore, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 69 electroCore, Inc.: Product Benchmarking
  • Table 70 electroCore, Inc.: Strategic Outlook
  • Table 71 Helbling Holding AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 72 Helbling Holding AG: Product Benchmarking
  • Table 73 Helbling Holding AG: Strategic Outlook
  • Table 74 Innovative Health Solutions: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 75 Innovative Health Solutions: Product Benchmarking
  • Table 76 LivaNova PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 77 LivaNova PLC: Product Benchmarking
  • Table 78 LivaNova PLC: Strategic Outlook
  • Table 79 Medtronic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 80 Medtronic: Product Benchmarking
  • Table 81 Medtronic: Strategic Outlook
  • Table 82 MicroTransponder Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 83 MicroTransponder Inc.: Product Benchmarking
  • Table 84 MicroTransponder Inc..: Strategic Outlook
  • Table 85 Neuronetics Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 86 Neuronetics Inc.: Product Benchmarking
  • Table 87 Neuronetics Inc.: Strategic Outlook
  • Table 88 Parasym: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 89 Parasym: Product Benchmarking
  • Table 90 Parasym: Strategic Outlook
  • Table 91 Synapse Biomedical Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 92 Synapse Biomedical Inc.: Product Benchmarking
  • Table 93 Synapse Biomedical Inc.: Strategic Outlook
  • Table 94 tVNS Technologies GmbH.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 95 tVNS Technologies GmbH.: Product Benchmarking
  • Table 96 tVNS Technologies GmbH.: Strategic Outlook
  •  

List of Figures

  • Figure 1 Neuromodulation Devices Market Segmentation
  • Figure 2 Neuromodulation Devices Market by Product: Market Attractiveness Index
  • Figure 3 Neuromodulation Devices Market by Application: Market Attractiveness Index
  • Figure 4 Neuromodulation Devices Market Attractiveness Index by Region
  • Figure 5 Neuromodulation Devices Market: Market Dynamics
  • Figure 6 Neuromodulation Devices Market by Region, 2024-2034 (US$ Million, AGR %): "V" Shaped Recovery
  • Figure 7 Neuromodulation Devices Market by Region, 2024-2034 (US$ Million, AGR %): "U" Shaped Recovery
  • Figure 8 Neuromodulation Devices Market by Region, 2024-2034 (US$ Million, AGR %): "W" Shaped Recovery
  • Figure 9 Neuromodulation Devices Market by Region, 2024-2034 (US$ Million, AGR %): "L" Shaped Recovery
  • Figure 10 Neuromodulation Devices Market: Porter's Five Forces Analysis
  • Figure 11 Neuromodulation Devices Market: PEST Analysis
  • Figure 12 Neuromodulation Devices Market by Product: Market Attractiveness Index
  • Figure 13 Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 14 Neuromodulation Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 15 Deep Brain Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 16 Deep Brain Stimulator Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 17 Gastric Electric Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 18 Gastric Electric Stimulator Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 19 Spinal Cord Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 20 Spinal Cord Stimulator Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 21 Sacral Nerve Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 22 Sacral Nerve Stimulator Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 23 Vagus Nerve Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 24 Vagus Nerve Stimulator Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 25 Transcutaneous Electrical Nerve Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 26 Transcutaneous Electrical Nerve Stimulator Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 27 Others Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 28 Others Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 29 Neuromodulation Devices Market by Application: Market Attractiveness Index
  • Figure 30 Neuromodulation Devices Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 31 Neuromodulation Devices Market Share Forecast by Application, 2024, 2029, 2034 (%)
  • Figure 32 Pain Management Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 33 Pain Management Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 34 Epilepsy Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 35 Epilepsy Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 36 Essential Tremor Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 37 Essential Tremor Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 38 Urinary and Fecal Incontinence Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 39 Urinary and Fecal Incontinence Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 40 Depression Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 41 Depression Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 42 Dystonia Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 43 Dystonia Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 44 Gastroparesis Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 45 Gastroparesis Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 46 Parkinson's Disease Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 47 Parkinson's Disease Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 48 Others Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 49 Others Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 50 Neuromodulation Devices Market Forecast by Region 2024 and 2034 (Revenue, CAGR %)
  • Figure 51 Neuromodulation Devices Market Share Forecast by Region 2024, 2029, 2034 (%)
  • Figure 52 Neuromodulation Devices Market by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 53 North America Neuromodulation Devices Market Attractiveness Index
  • Figure 54 North America Neuromodulation Devices Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 55 North America Neuromodulation Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 56 North America Neuromodulation Devices Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 57 North America Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 58 North America Neuromodulation Devices Market Share Forecast by Product, 2024 & 2034 (%)
  • Figure 59 North America Neuromodulation Devices Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 60 North America Neuromodulation Devices Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 61 U.S. Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 62 Canada Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 63 Europe Neuromodulation Devices Market Attractiveness Index
  • Figure 64 Europe Neuromodulation Devices Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 65 Europe Neuromodulation Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 66 Europe Neuromodulation Devices Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 67 Europe Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 68 Europe Neuromodulation Devices Market Share Forecast by Product, 2024 & 2034 (%)
  • Figure 69 Europe Neuromodulation Devices Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 70 Europe Neuromodulation Devices Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 71 Germany Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 72 France Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 73 UK Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 74 Italy Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 75 Spain Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 76 Russia Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 77 Rest of Europe Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 78 Asia Pacific Neuromodulation Devices Market Attractiveness Index
  • Figure 79 Asia Pacific Neuromodulation Devices Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 80 Asia Pacific Neuromodulation Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 81 Asia Pacific Neuromodulation Devices Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 82 Asia Pacific Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 83 Asia Pacific Neuromodulation Devices Market Share Forecast by Product, 2024 & 2034 (%)
  • Figure 84 Asia Pacific Neuromodulation Devices Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 85 Asia Pacific Neuromodulation Devices Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 86 Japan Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 87 China Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 88 India Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 89 Australia Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 90 South Korea Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 91 Rest of Asia Pacific Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 92 Latin America Neuromodulation Devices Market Attractiveness Index
  • Figure 93 Latin America Neuromodulation Devices Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 94 Latin America Neuromodulation Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 95 Latin America Neuromodulation Devices Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 96 Latin America Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 97 Latin America Neuromodulation Devices Market Share Forecast by Product, 2024 & 2034 (%)
  • Figure 98 Latin America Neuromodulation Devices Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 99 Latin America Neuromodulation Devices Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 100 Brazil Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 101 Mexico Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 102 Rest of Latin America Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 103 MEA Neuromodulation Devices Market Attractiveness Index
  • Figure 104 MEA Neuromodulation Devices Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 105 MEA Neuromodulation Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 106 MEA Neuromodulation Devices Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 107 MEA Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 108 MEA Neuromodulation Devices Market Share Forecast by Product, 2024 & 2034 (%)
  • Figure 109 MEA Neuromodulation Devices Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 110 MEA Neuromodulation Devices Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 111 GCC Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 112 South Africa Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 113 Rest of MEA Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 114 Neuromodulation Devices Market: Company Share, 2022
  • Figure 115 Abbott: Net Revenue, 2017-2022 (US$ million, AGR%)
  • Figure 116 Abbott: R&D, 2017-2022 (US$ million, AGR%)
  • Figure 117 Abbott: Regional Market Shares, 2022
  • Figure 118 Boston Scientific Corporation.: Net Revenue, 2017-2022 (US$ million, AGR%)
  • Figure 119 Boston Scientific Corporation, Inc.: R&D, 2017-2022 (US$ million, AGR%)
  • Figure 120 Boston Scientific Corporation, Inc.: Regional Market Shares, 2022
  • Figure 121 electroCore, Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 122 electroCore, Inc.: R&D, 2017-2022 (US$ Million, AGR%)
  • Figure 123 electroCore, Inc.: Regional Market Shares, 2022
  • Figure 124 Helbling Holding AG: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 125 LivaNova PLC: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 126 LivaNova PLC: R&D, 2017-2022 (US$ Million, AGR%)
  • Figure 127 LivaNova PLC: Regional Market Shares, 2022
  • Figure 128 Medtronic: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 129 Medtronic: R&D, 2017-2022 (US$ Million, AGR%)
  • Figure 130 Medtronic: Regional Market Shares, 2022
  • Figure 131 Neuronetics, Inc: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 132 Neuronetics, Inc: R&D, 2017-2022 (US$ Million, AGR%)
  • Figure 133 Neuronetics, Inc: Regional Market Shares, 2022